Acorn Capital Advisors, LLC Portfolio Holdings

Acorn Capital Advisors, LLC

  • $185 Billion
  • Q4 2024

Acorn Capital Advisors, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $185 Billion distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cg Oncology Inc with a value of $32.5B, Y M Abs Therapeutics, Inc. with a value of $22.4B, Candel Therapeutics, Inc. with a value of $16.8B, Uro Gen Pharma Ltd. with a value of $16.1B, and Puma Biotechnology, Inc. with a value of $12B.

Examining the 13F form we can see an increase of $185B in the current position value.

Acorn Capital Advisors, LLC is based out at New York, NY

Below you can find more details about Acorn Capital Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $185 Billion
Healthcare: $111 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Cg Oncology Inc
-
$32.5 Billion 17.54% of portfolio
-
Q4 2024 New
$273M
$22.4 Billion 12.11% of portfolio
2,861,825
Q4 2024 New
$261M
$16.8 Billion 9.1% of portfolio
1,939,644
Q4 2024 New
$245M
$16.1 Billion 8.73% of portfolio
1,516,303
Q4 2024 New
$130M
$12 Billion 6.49% of portfolio
2,450,711
Q4 2024 New
Bicara Therapeutics
-
$11.2 Billion 6.06% of portfolio
-
Q4 2024 New
$153M
$10.9 Billion 5.9% of portfolio
1,971,264
Q4 2024 New
Onkure Therapeutics Inc
-
$10.2 Billion 5.54% of portfolio
-
Q4 2024 New
$237M
$8.24 Billion 4.46% of portfolio
2,001,048
Q4 2024 New
$46.9M
$6.76 Billion 3.65% of portfolio
1,279,800
Q4 2024 New
Cybin Inc
-
$6.48 Billion 3.5% of portfolio
-
Q4 2024 New
$186M
$6.26 Billion 3.38% of portfolio
1,442,308
Q4 2024 New
$35M
$5.36 Billion 2.9% of portfolio
7,310,650
Q4 2024 New
Mural Oncology PLC
-
$4.14 Billion 2.24% of portfolio
-
Q4 2024 New
$54.4M
$3.62 Billion 1.96% of portfolio
1,147,052
Q4 2024 New
Optinose Inc
-
$2.82 Billion 1.53% of portfolio
-
Q4 2024 New
-
$2.44 Billion 1.32% of portfolio
-
Q4 2024 New
$16.7M
$2.38 Billion 1.29% of portfolio
4,032,046
Q4 2024 New
Vyne Therapeutics Inc
-
$1.53 Billion 0.83% of portfolio
-
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $185 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 20 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Acorn Capital Advisors, LLC Portfolio

Follow Acorn Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acorn Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acorn Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email